CEBPZ and acute myeloid leukemia: The presence of disease defining recurrent fusion transcripts associated with CBF‐AML enable the serial monitoring by real‐time quantitative reverse transcription polymerase chain reaction (qRTPCR) for detection of measurable residual disease (MRD).11, 12, 13